Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs

BACKGROUND: Scaled-up direct-acting antiviral (DAA) treatment of hepatitis C virus (HCV) infection among people who inject drugs (PWID) is crucial to reach the World Health Organization HCV elimination targets within 2030. One of the critical obstacles to HCV care in this population is the lack of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Midgard, H., Finbråten, A. K., Malme, K. B., Berg-Pedersen, R. M., Tanum, L., Olsen, I. C., Bjørnestad, R., Dalgard, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294626/
https://www.ncbi.nlm.nih.gov/pubmed/32539853
http://dx.doi.org/10.1186/s13063-020-04434-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294626/
https://www.ncbi.nlm.nih.gov/pubmed/32539853
http://dx.doi.org/10.1186/s13063-020-04434-8

Ejemplares similares